New Delhi: IIT Delhi is proud to announce the inauguration of a state-of-the-art CNC and Sterilization & Packaging lab at mPragati, IIT Delhi, a national translational platform dedicated to advancing medical device and diagnostics innovation. Dr. Rajiv Bahl, Secretary to Government of India, Department of Health Research and Director General, Indian Council of Medical Research, inaugurated the facilities.
Dr. Suchita Markan, Head, Innovation and Translation Research, ICMR; Prof. Rangan Banerjee, Director, IIT Delhi Prof. Ashwini Agrawal, Dean R&D; Prof. Manidipa Banerjee, Head CRF; and Prof. Dinesh Kalyanasundaram, Coordinator, mPragati, IIT Delhi, were present on this occasion.
The CNC facility provides state-of-the-art precision machining for medical implants, surgical instruments, dental devices, and diagnostic components — enabling indigenous manufacturing with certified biocompatible materials.
With advanced multi-axis machining, Swiss-type turning, and high-speed milling, the CNC facility supports both patient-specific and standardized components. It bridges a critical gap in India’s MedTech value chain by reducing reliance on imports and accelerating translation of prototypes into clinically deployable products.
The Sterilization & Packaging Facility provides an end-to-end infrastructure for the development, validation, sterilization, and packaging of medical devices, diagnostics, and biomedical products. The facility is equipped with advanced sterilization systems, including Ethylene Oxide (EtO) and steam autoclaves, precision device assembly workstations, automated reagent dispensing systems, stability chambers for reagent and product shelf-life validation, a high-precision laser welding system, laser marking, and secure vacuum packaging integrated with batch coding and product traceability.
Complementing these capabilities is a comprehensive biological and molecular testing infrastructure comprising thermal cyclers, real-time PCR systems, Trans-Blot systems, gel electrophoresis and gel documentation systems, high-speed ultracentrifuges, HPLC, CO₂ incubators, fluorescence microscopy, biosafety cabinets for mammalian cell culture, and ultra-low temperature storage.
Together, these facilities support molecular diagnostics, analytical testing, biological validation, sterility assurance, quality control, and regulatory compliance, enabling the translation of innovative medical technologies from laboratory research to clinical and commercial deployment.
Strategic Impact & National Alignment
These facilities bridge the gap between laboratory innovation and product commercialization, reduce dependence on imported precision medical components, and accelerate deployment of indigenous technologies to improve patient care. They directly strengthen India’s capability to design, validate, and commercialize high-quality medical devices in line with the vision of Atmanirbhar Bharat, while supporting ICMR’s mission of translational biomedical research and advancing national healthcare priorities.
